R ecently, differences in the management of men and women with ischemic heart disease have been highlighted. 1 Although at least as great, sex differences in heart failure have received little attention. In this article, we review the evidence that men and women with heart failure may differ with respect to epidemiology, etiology, diagnosis, prognosis, and treatment.
EpidemiologyTo date, most studies of the prevalence and incidence of heart failure have identified cases on clinical grounds and, in some instances, with the aid of an ECG and chest radiograph. Thus, the precise type of heart failure (eg, left ventricular systolic dysfunction, or valvular disease) is unclear in most reports. This is important in view of the evidence that left ventricular systolic dysfunction is less common in women than in men with suspected heart failure (see the "Diagnosis" section below).
PrevalenceWith these caveats in mind, the major epidemiological surveys of heart failure (see the Figure) 2-5 show that the overall prevalence rate of heart failure is similar in men and women. This balance, however, reflects a much lower female prevalence Ͻ70 to 75 years of age and a higher prevalence in older women than in older men. Overall, within the population, there appear to be more women than men with heart failure. 6-8a Although age-adjusted rates for both sexes have decreased from 1988 -1995, rates for women have fallen less than those for men. 8b
IncidenceAlthough the absolute incidence rate is lower than the prevalence rate, the effect of age on sex incidence is similar. 3
EtiologyRisk factors for heart failure appear to differ markedly between the sexes. Peripartum cardiomyopathy is a rare but important disorder that has been reviewed elsewhere. 32
X-Linked CardiomyopathyFamilies with patterns of inheritance suggesting an X-linked cardiomyopathy have been described. [33][34][35][36][37] Clinical expression is that of early onset and rapid progression in men and later Sex differences in prevalence of heart failure and left ventricular systolic dysfunction in major epidemiological studies. *Based on clinical criteria; **based on echocardiography.
In postmenopausal women with coronary heart disease, estrogen therapy inhibits the vasoconstrictor response to ET-1 after one month of therapy. This effect is lost after three months of therapy, suggesting that tachyphylaxis to one potentially beneficial action of estradiol develops during chronic treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.